FDA Inspection
Pfizer Ireland Pharmaceuticals Unlimited CompanyPfizer Ireland Pharmaceuticals Unlimited Company – FDA Inspection, Sep 18, 2018
Record Details
This FDA Inspection record concerns Pfizer Ireland Pharmaceuticals Unlimited Company, with an inspection on September 18, 2018, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- September 18, 2018
- Product Type
- Biologics
View Company Profile
ID · 40f0696e-b593-42fb-a26d-f710df3d6a13
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1066269
- FDA center
- Biologics
- Project area
- Vaccines and Allergenic Products
- Outcome
- Form 483 issued
Other FDA inspections of Pfizer Ireland Pharmaceuticals Unlimited Company
12| Date | Classification | Office | Project area |
|---|---|---|---|
| December 15, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 11, 2023 | Not classified | Office of Inspections and Investigations | |
| January 24, 2023 | Not classified | Office of Inspections and Investigations | |
| November 12, 2019 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| November 9, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Pfizer Ireland Pharmaceuticals Unlimited Company
- FDA Inspection 1270977 - 2023-12-15
- FDA Inspection 1208210 - 2023-05-11
- FDA Inspection 1201722 - 2023-01-24
- FDA Inspection 1109599 - 2019-11-12
- FDA Inspection 1112255 - 2018-11-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.